SG Americas Securities, LLC - BIOMARIN PHARMACEUTICAL INC ownership

BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061G951. A total of 5 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of BIOMARIN PHARMACEUTICAL INC
ValueSharesWeighting
Q4 2020$60,000
-80.0%
30,0000.0%0.00%
-100.0%
Q3 2020$300,000
+650.0%
30,000
-46.7%
0.00%
Q4 2017$40,000
-73.5%
56,3000.0%0.00%
-100.0%
Q3 2017$151,000
+16.2%
56,300
+302.1%
0.00%0.0%
Q4 2016$130,000
+44.4%
14,0000.0%0.00%0.0%
Q3 2016$90,000
-61.5%
14,0000.0%0.00%
-50.0%
Q2 2016$234,000
-0.4%
14,0000.0%0.00%0.0%
Q1 2016$235,000
+86.5%
14,0000.0%0.00%
+100.0%
Q4 2015$126,000
-32.3%
14,0000.0%0.00%0.0%
Q3 2015$186,000
+165.7%
14,0000.0%0.00%
Q2 2015$70,000
-33.3%
14,0000.0%0.00%
-100.0%
Q1 2015$105,00014,0000.00%
Other shareholders
BIOMARIN PHARMACEUTICAL INC shareholders Q4 2017
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 146,800$12,161,0000.12%
Hudson Bay Capital Management LP 50,000$4,142,0000.04%
SIMPLEX TRADING, LLC 404$225,0000.01%
Timber Hill LLC 12,100$1,002,0000.01%
JPMORGAN CHASE & CO 40,000$3,314,0000.00%
SG Americas Securities, LLC 14,000$130,0000.00%
View complete list of BIOMARIN PHARMACEUTICAL INC shareholders